MoLO study - Evaluation of cost/efficacy ratio of monotherapy with lopinavir/ritonavir versus standard in patients treated with protesi inhibotors in virologic suppressison. - ND
- Conditions
- chronic HIV infectionMedDRA version: 12.1Level: LLTClassification code 10008922Term: Chronic infection with HIV
- Registration Number
- EUCTR2008-007765-23-IT
- Lead Sponsor
- SIMIT sezione Regione Lombardia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
age over or equal to 18; HIV infection in stable treatment con PI and nucleosidic analogs from at least 6 months; HIV-RNA< 50 copies/ml from at least 6 months; etc.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
nadir linfocyte CD4+ <50/?l, previous failure to PI etc.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method